A £310 million cut in UK medical research investment is predicted this year

The partnership will develop and commercialise novel custom antibodies for cancer research

This follows a positive review from the Independent Data Monitoring Committee of REGN-COV2 Phase I safety results

CureVac scores $85M loan to scale COVID-19 shot manufacturing at German site kblankenship Mon, 07/06/2020 – 19:03

J&J expands COVID-19 vaccine pact with Catalent for finishing work at Italian facility kblankenship Mon, 07/06/2020 – 19:28

Updated Date: Mon, 29 Jun 2020 00:00:00 EDT

Updated Date: Mon, 29 Jun 2020 00:00:00 EDT

Updated Date: Mon, 29 Jun 2020 00:00:00 EDT

Updated Date: Mon, 29 Jun 2020 00:00:00 EDT

Updated Date: Mon, 29 Jun 2020 00:00:00 EDT